Extreme Heat and Healthcare in the U.S.
-
Register
- User - $27.50
The frequency, duration, and intensity of heat waves in the United States have increased in recent decades, causing significant physical and mental health impacts. Extreme heat kills more people on average (approximately 1,220 deaths per year in the United States) than hurricanes, floods, tornadoes, earthquakes, and lightning combined. During this 1 hour presentation, participants will learn about the most up-to-date evidence based science on the impact of extreme heat and population health, how to identify patients in the clinical setting with increased vulnerabilities, as well as tools and resources to help guide best practice.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.0 Contact Hours; 0 are Pharmacology
This activity is designated for 1 AAPA Category 1 CME Credits. PAs should claim credit commensurate with the extent of their participation. Approval is valid from 9/19/24 to 9/18/25.
Expiration Date: September 18, 2025
$27.50
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Discuss the current science on the impact of extreme heat due to climate change on human health
-Identify populations with increased vulnerabilities
-Describe advocacy action steps healthcare providers can take in policy and practic
Milagros R. Elia, M.A, APRN, ANP-BC
Milagros R. Elia, M.A, APRN, ANP-BC, is the Program Manager of Climate and Clean Energy Advocacy at the Alliance of Nurses for Healthy Environments.
As an Advanced Practice Registered Nurse, Milagros is deeply involved in understanding the environmental impact of climate change on population health. Her role as an early-stage researcher allows her to contribute to the field's knowledge base. Milagros is also a Fellow of the American Nurses Advocacy Institute, where she is focused on building awareness and developing educational toolkits on the impact of climate change on patient care and outcomes. Additionally, she currently Chairs the National American Nurses Association’s Innovation Advisory Committee on Planetary and Global Health.
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 9/19/2024 to 9/18/2025 . PAs should only claim credit commensurate with the extent of their participation
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720.
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 9/19/2024 to 9/18/2025 . PAs should only claim credit commensurate with the extent of their participation
DISCLOSURES
Faculty
Contributing faculty, Milagros R. Elia, M.A, APRN, ANP-BC has disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
